Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.637 EUR | +1.28% | +7.83% | -22.94% |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Mar. 26 | Valneva: Phase 1 trial initiated in the Zika virus | CF |
- Stock
- Equities
- Stock Valneva - Euronext Paris
- News Valneva